Skip to main content

Pharmacy

By Susan Morse | 10:39 am | October 29, 2015
Pharmaceutical giant Pfizer is reportedly poised to buy Botox-maker Allergan, in what would be one of the biggest takeover deal this year, according to The Wall Street Journal.
By Susan Morse | 03:04 pm | October 27, 2015
Rite Aid has worked to expand its RediClinics, walk-in health centers, while Walgreens has aggressively expanded its walk-in clinic business.
By Henry Powderly | 10:45 am | October 23, 2015
Turing Pharmaceuticals chief Martin Shkreli will face new competition for Daraprim, the AIDS drug he recently hiked 5,000 percent in price, after competitor Imprimis Pharmaceuticals on Thursday said it will market a similar drug for just $1 a tablet.
By Susan Morse | 09:55 am | October 22, 2015
The medication therapy management model is being tested in five regions as an incentive to boost adherence for stand-alone Part D plans not connected with Medicare Advantage.
By Susan Morse | 02:17 pm | October 21, 2015
America's Health Insurance Plans on Wednesday called former Secretary of State Hillary Clinton's stance against major insurance company consolidation misguided, and suggested that the presidential candidate focus on other issues plaguing healthcare instead.
By Susan Morse | 10:38 am | October 21, 2015
Nearly every C-suite respondent to Premier's 2015 Economic Outlook said pharmaceutical price increases are their top area of concern.
By Susan Morse | 08:56 am | October 19, 2015
Proposed Environmental Protection Agency rules for the disposal of hazardous waste pharmaceuticals will prevent hospitals and other healthcare facilities from flushing drugs down the toilet or drain.
By Kaiser Health News | 08:30 am | October 19, 2015
A jump in the number of new expensive drugs hitting the market -- along with moves by drugmakers like Turing to raise the price on older and generic drugs -- have helped make prescription drugs the fastest-growing segment of the nation's health care tab.
By Susan Morse | 11:18 am | October 16, 2015
The American Hospital Association is blasting a court ruling siding with the Pharmaceutical Research and Manufacturers of America over the 340B Orphan Drug program, according to AHA Executive Vice President Tom Nickels.
By Kaiser Health News | 08:46 am | October 06, 2015
Chronically ill people enrolled in individual health plans sold on the Affordable Care Act insurance exchanges pay on average twice as much out-of-pocket for prescription drugs each year than people covered through their workplace, according to a study published Monday in the Health Affairs journal.